Abstract

Background: Oncoplastic breast conserving surgery has evolved to allow for higher breast volume excision without compromising cosmesis. Volume replacement, involving the use of autologous tissue, aims to fill the excised defect thus eliminating deformity and maintaining breast appearance. There are a variety of chest wall perforator flaps (CWPF) including lateral intercostal artery perforator (LICAP), anterior intercostal artery perforator (AICAP), and medial intercostal artery perforator (MICAP) flaps. The aim of this study was to assess the oncological and surgical outcomes of patients undergoing CWPF in a single tertiary centre.